Investment led by BGF, with support from existing investors F-Prime Capital, Kindred Capital, and Jonathan Milner Seed funding will accelerate development of Shift Bioscience’s platform for ...
Shift Bioscience is a biotech company using generative AI models to understand how activation of different genes can reverse the aging process. This research is a fundamental step forward in designing ...
LONDON & BUDAPEST, Hungary--(BUSINESS WIRE)--In a landmark move, the FDA recently announced plans to phase out the requirement for animal testing in drug development, encouraging the use of ...
Shift Bioscience, a biotech company using an AI powered virtual cell to fight age-related diseases, today announced the establishment of a new North American team and facilities to advance development ...